BioengineeringbioRxivPreprint
Saponin Nanoparticle Adjuvants Incorporating Toll-Like Receptor Agonists Drive Distinct Immune Signatures and Potent Vaccine Responses
B. S. Ou, J. Baillet, M. V. Filsinger Interrante…·E. Appel
This paper develops a modular saponin-based nanoparticle adjuvant platform incorporating TLR agonists, showing improved vaccine potency and breadth against COVID-19 and HIV in mice.
DOI 10.1101/2023.07.16.549249